Skip to main content
. 2022 Feb 10;10:836984. doi: 10.3389/fbioe.2022.836984

FIGURE 4.

FIGURE 4

A bench-to-bedside approach using 3D cell cultures to fast track personalized therapies for ovarian cancers. Utilization of (A) samples from multiple patient tumor sites, (B) isolation of cancer cells ex vivo for (C) molecular profiling and (D) propagation as 3D cell cultures can identify clues regarding a patient’s unique tumor phenotype. Based on these findings, (E) a high-throughput drug screen of molecularly relevant drugs in 3D cell cultures can be employed to predict drug efficacy and utilized to guide a personalized medicine approach. Created with Biorender.com.